factual
MERS work gave specific SARS-CoV-2 knowledge
Moderna's prior year-and-a-half partnership with NIH/NIAID (Fauci's group) on a MERS vaccine—MERS being a close cousin of SARS-CoV-2—gave them specific knowledge about the particular protein to target, contributing to the rapid COVID vaccine development.
factualpending
Speaker
Noubar AfeyanEvidence Quote
“together with NIH and the NIAID, Dr. Fauci's group — on the particular protein that we needed to go after”
Created: 6/12/2026, 4:54:48 PM
Your notes
Loading notes...